Nonavalent HPV vaccine vs quadrivalent HPV vaccine
Overall systemic events and general symptoms · 9‐ to 26‐year‐old females and males
Nonavalent HPV vaccine showed no clear difference in overall systemic events and general symptoms at 15‐day compared with quadrivalent HPV vaccine (moderate certainty).
1 finding from 1 review
- Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes onlyRR 1.01 [0.98, 1.04]3 studies · 15863 participantsModerate